Suppr超能文献

亚临床皮质醇增多症:生化诊断标准与临床方面的相关性。

Subclinical hypercortisolism: correlation between biochemical diagnostic criteria and clinical aspects.

机构信息

Unit of Endocrinology and Diabetology, Department of Medical Sciences, Università degli Studi di Milano, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan.

出版信息

Clin Endocrinol (Oxf). 2010 Aug;73(2):161-6. doi: 10.1111/j.1365-2265.2010.03794.x. Epub 2010 Feb 23.

Abstract

OBJECTIVE

Subclinical hypercortisolism (SH) has been associated with increased prevalence of hypertension, type 2 diabetes mellitus, dyslipidaemia, central obesity, osteoporosis and vertebral fractures. We aimed to investigate the accuracy of different SH diagnostic criteria in predicting the presence of complications.

DESIGN

This was a retrospective study.

PATIENTS

We evaluated data from 231 patients (120 women and 111 men) affected with adrenal incidentalomas (AI).

MEASUREMENTS

We studied the accuracy of different SH diagnostic criteria (cortisol after 1 mg overnight dexamethasone suppression test - 1mg-DST - at different cut-off such as 49.7, 82.8, 137.9 nmol/l, elevated urinary free cortisol, reduced adrenal corticotroph hormone (ACTH) levels alone or various combination of these parameters) in predicting the concomitant presence of the following three complications: hypertension, type 2 diabetes and vertebral fractures.

RESULTS

The criterion characterized by the presence of two of 1mg-DST >82.8 nmol/l, elevated UFC and reduced ACTH struck the best balance between sensitivity and specificity, reaching a good accuracy in predicting the cluster of complications (61.9%; 77.1% and 75.8%, respectively). The presence of this cluster was associated with this criterion (OR 4.75, 95%CI 1.8-12.7, P = 0.002) regardless of gonadal status, body mass index (BMI) and age.

CONCLUSIONS

The SH criterion characterized by the presence of two of 1mg-DST >82.8 nmol/l, elevated UFC and reduced ACTH seems the best in predicting the presence of chronic manifestations of subtle cortisol excess.

摘要

目的

亚临床皮质醇增多症(SH)与高血压、2 型糖尿病、血脂异常、中心性肥胖、骨质疏松症和椎体骨折的患病率增加有关。我们旨在研究不同 SH 诊断标准预测并发症存在的准确性。

设计

这是一项回顾性研究。

患者

我们评估了 231 例(120 名女性和 111 名男性)患有肾上腺意外瘤(AI)的患者的数据。

测量

我们研究了不同 SH 诊断标准(不同截断值(如 49.7、82.8、137.9nmol/L)的 1mg 过夜地塞米松抑制试验(1mg-DST)后皮质醇、升高的尿游离皮质醇、单独降低的促肾上腺皮质激素(ACTH)水平或这些参数的各种组合)在预测以下三种并发症同时存在的准确性:高血压、2 型糖尿病和椎体骨折。

结果

以存在 1mg-DST>82.8nmol/L、升高的 UFC 和降低的 ACTH 这两个标准为特征的标准,在灵敏度和特异性之间取得了最佳平衡,在预测并发症群方面具有良好的准确性(分别为 61.9%、77.1%和 75.8%)。该标准的存在与这种标准相关(OR 4.75,95%CI 1.8-12.7,P=0.002),与性别、体重指数(BMI)和年龄无关。

结论

以存在 1mg-DST>82.8nmol/L、升高的 UFC 和降低的 ACTH 这两个标准为特征的 SH 标准似乎是预测轻微皮质醇过量的慢性表现存在的最佳标准。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验